Fortis Healthcare Limited has submitted its comprehensive disclosure under the SEBI Master Circular for Centralized Database for Corporate Bonds/Debentures for the financial year ended March 31, 2026. The healthcare major filed the mandatory Annexure XIV-B on April 10, 2026, detailing outstanding debt securities totaling ₹1,550 crore across three separate tranches issued through private placement.

Debt Securities Portfolio and Listing Details

The company's debt securities portfolio comprises three distinct issuances, all executed and listed on December 19, 2024, with identical maturity dates of December 19, 2029. All securities are listed on BSE as first issues, each carrying specific ISIN numbers with both old and new identifiers.

Credit Rating Enhancement and Current Status

Fortis Healthcare received a credit rating upgrade from CRISIL, with all three debt securities now carrying a CRISIL AA+ rating with stable outlook as of September 01, 2025. This represents an upgrade from the initial CRISIL AA rating assigned on October 01, 2024, when the securities were first issued.

Interest Payment Performance

The company has successfully completed its first annual interest payment cycle for all three tranches. The interest payments were made on December 22, 2025, with a record date of December 5, 2025, demonstrating timely compliance with debt servicing obligations.

Regulatory Compliance and Documentation

The disclosure was submitted by Company Secretary and Compliance Officer Satyendra Chauhan, ensuring full compliance with SEBI Master Circular SEBI/HO/DDHS/DDHS-PoD/P/CIR/2025/0000000137 dated October 15, 2025. The filing includes hyperlinks to BSE listing notifications and confirms no default history for any debt securities issued by the company. All three debt securities maintain uniform terms with annual coupon reset provisions and step-up/step-down mechanisms as per the original issuance terms.

Fortis Healthcare is positioned to play a pivotal role in IHH Healthcare's expanded India strategy, as the Malaysian healthcare giant announces plans to move more capital into the Indian market using Fortis as its primary investment vehicle.

Strategic Investment Vehicle

IHH Healthcare has revealed its intention to channel additional capital into India through Fortis Healthcare, leveraging the Indian healthcare provider as its key investment platform. This strategic approach demonstrates IHH's commitment to deepening its presence in one of Asia's fastest-growing healthcare markets.

Capital Deployment Strategy

The announcement indicates IHH Healthcare's confidence in using Fortis Healthcare as the cornerstone of its India growth strategy. By positioning Fortis as its investment vehicle, IHH aims to capitalize on India's expanding healthcare sector while leveraging Fortis's established market presence and operational expertise.

This approach allows IHH to concentrate its India investments through a single, well-positioned platform rather than pursuing multiple separate ventures. The strategy could enable more efficient capital allocation and streamlined operations across IHH's Indian healthcare investments.

Market Implications

The decision to use Fortis Healthcare as an investment vehicle reflects IHH's long-term commitment to the Indian healthcare market. This consolidated approach may provide Fortis with enhanced financial backing for expansion initiatives and infrastructure development.

The move positions Fortis Healthcare as a central component of IHH's regional expansion strategy, potentially strengthening its competitive position in India's healthcare landscape.